In Other News

• Rapid Biosensor Detects Drug Sensitivity in Breast Tumors

• Study Reveals Diagnostic and Therapeutic Target in Rare Pancreatic Tumors

• FDA Approval Expands Use of PD-L1 Companion Diagnostic in Esophageal and GEJ Carcinomas

• WHO Endorses Rapid Point-of-Care Testing to Improve TB Detection

• New CLIA Status Brings Mass Spectrometry Steroid Testing to Routine Labs

• First IVDR‑Certified IGH Clonality Assay Supports Diagnosis of B-Cell Malignancies

• Rapid Biosensor Detects Drug Sensitivity in Breast Tumors

• Large-Scale Study Maps DNA Damage Signatures Across Multiple Cancers

• New CLIA Status Brings Mass Spectrometry Steroid Testing to Routine Labs

• Study Shows Dual Biomarkers Improve Accuracy of Alzheimer’s Detection

• First IVDR‑Certified IGH Clonality Assay Supports Diagnosis of B-Cell Malignancies

• Large-Scale Study Maps DNA Damage Signatures Across Multiple Cancers

• Portable Test Uses CRISPR to Rapidly Identify STIs and Resistance Markers

• Plasma ctDNA Testing Predicts Breast Cancer Recurrence After Neoadjuvant Therapy

• Online Tool Supports Family Screening for Inherited Cancer Risk

• Blood-Based Screening Test Targets Early Detection of Colorectal Cancer

• Automated NfL Assay Supports Monitoring of Neurological Disorders

• New Respiratory Panel Expands Pathogen Detection to 25 Targets

• Biopsy-Based Gene Test Predicts Recurrence Risk in Lung Adenocarcinoma

• Nasal Swab May Reveal Early Signs of Alzheimer’s Disease

• Integrated DNA Technologies Expands into Clinical Diagnostics

• Study Identifies Inflammatory Pathway Driving Immunotherapy Resistance in Bladder Cancer

• Smart Mask Delivers Continuous, Battery-Free Breath Monitoring